The present application relates to novel substituted quinoline-4-carboxamides, which act as stimulators of soluble guanylate cyclase, and to the use thereof, to methods for the production thereof, to the use thereof alone or in combinations to treat and/or prevent diseases, and to the use thereof to produce drugs for treating and/or preventing diseases, in particular for treating and/or preventing cardiovascular diseases.